Teertam S, Setaluri V, Ayuso J
JID Innov. 2024; 5(1):100315.
PMID: 39525704
PMC: 11550131.
DOI: 10.1016/j.xjidi.2024.100315.
Yang Z, Yu J, Wong C
Cells. 2024; 13(16.
PMID: 39195202
PMC: 11352269.
DOI: 10.3390/cells13161312.
Abbasi-Malati Z, Khanicheragh P, Narmi M, Mardi N, Khosrowshahi N, Hiradfar A
Stem Cell Res Ther. 2024; 15(1):267.
PMID: 39183337
PMC: 11346257.
DOI: 10.1186/s13287-024-03880-4.
Aljabali A, Obeid M, Mishra V, El-Tanani M, Tambuwala M
Curr Drug Deliv. 2024; 21(10):1285-1299.
PMID: 39034714
DOI: 10.2174/0115672018264064231017113813.
Li X, Wang M, Davis T, Zhang L, Qiao R
Biosensors (Basel). 2024; 14(6).
PMID: 38920605
PMC: 11201418.
DOI: 10.3390/bios14060301.
Knockout cancer by nano-delivered immunotherapy using perfusion-aided scaffold-based tumor-on-a-chip.
Suryavanshi P, Bodas D
Nanotheranostics. 2024; 8(3):380-400.
PMID: 38751938
PMC: 11093718.
DOI: 10.7150/ntno.87818.
Fabrication strategies for chiral self-assembly surface.
Niu X, Yuan M, Zhao R, Wang L, Liu Y, Zhao H
Mikrochim Acta. 2024; 191(4):202.
PMID: 38492117
DOI: 10.1007/s00604-024-06278-4.
Open microfluidics: droplet microarrays as next generation multiwell plates for high throughput screening.
Strutt R, Xiong B, Abegg V, Dittrich P
Lab Chip. 2024; 24(5):1064-1075.
PMID: 38356285
PMC: 10898417.
DOI: 10.1039/d3lc01024d.
Scaffold-based 3D cell culture models in cancer research.
Abuwatfa W, Pitt W, Husseini G
J Biomed Sci. 2024; 31(1):7.
PMID: 38221607
PMC: 10789053.
DOI: 10.1186/s12929-024-00994-y.
Advances in screening hyperthermic nanomedicines in 3D tumor models.
Soeiro J, Sousa F, Monteiro M, Gaspar V, Silva N, Mano J
Nanoscale Horiz. 2024; 9(3):334-364.
PMID: 38204336
PMC: 10896258.
DOI: 10.1039/d3nh00305a.
Effects of Mechanical Stress on Endothelial Cells In Situ and In Vitro.
Katoh K
Int J Mol Sci. 2023; 24(22).
PMID: 38003708
PMC: 10671803.
DOI: 10.3390/ijms242216518.
Microfluidic Systems for Neural Cell Studies.
Babaliari E, Ranella A, Stratakis E
Bioengineering (Basel). 2023; 10(8).
PMID: 37627787
PMC: 10451731.
DOI: 10.3390/bioengineering10080902.
Bioreactor Technologies for Enhanced Organoid Culture.
Licata J, Schwab K, Har-El Y, Gerstenhaber J, Lelkes P
Int J Mol Sci. 2023; 24(14).
PMID: 37511186
PMC: 10380004.
DOI: 10.3390/ijms241411427.
Rapid Detection of Direct Compound Toxicity and Trailing Detection of Indirect Cell Metabolite Toxicity in a 96-Well Fluidic Culture Device for Cell-Based Screening Environments: Tactics in Six Sigma Quality Control Charts.
Lubamba B, Jensen T, McClelland R
Appl Sci (Basel). 2023; 12(6).
PMID: 37502123
PMC: 10374175.
DOI: 10.3390/app12062786.
Application of three-dimensional cell culture technology in screening anticancer drugs.
Sun Y, Ma H
Biotechnol Lett. 2023; 45(9):1073-1092.
PMID: 37421554
DOI: 10.1007/s10529-023-03410-x.
Development of a human malaria-on-a-chip disease model for drug efficacy and off-target toxicity evaluation.
Rupar M, Sasserath T, Smith E, Comiter B, Sriram N, Long C
Sci Rep. 2023; 13(1):10509.
PMID: 37380653
PMC: 10307889.
DOI: 10.1038/s41598-023-35694-4.
A review for cell-based screening methods in drug discovery.
Wei F, Wang S, Gou X
Biophys Rep. 2023; 7(6):504-516.
PMID: 37288368
PMC: 10210057.
DOI: 10.52601/bpr.2021.210042.
Optimizing culturing conditions in patient derived 3D primary slice cultures of head and neck cancer.
Greier M, Runge A, Dudas J, Carpentari L, Schartinger V, Randhawa A
Front Oncol. 2023; 13:1145817.
PMID: 37064104
PMC: 10101142.
DOI: 10.3389/fonc.2023.1145817.
Recent Advances in Organ-on-Chips Integrated with Bioprinting Technologies for Drug Screening.
Tabatabaei Rezaei N, Kumar H, Liu H, Lee S, Park S, Kim K
Adv Healthc Mater. 2023; 12(20):e2203172.
PMID: 36971091
PMC: 11469032.
DOI: 10.1002/adhm.202203172.
Recent Advances on Cell Culture Platforms for In Vitro Drug Screening and Cell Therapies: From Conventional to Microfluidic Strategies.
Cardoso B, Castanheira E, Lanceros-Mendez S, Cardoso V
Adv Healthc Mater. 2023; 12(18):e2202936.
PMID: 36898671
PMC: 11468737.
DOI: 10.1002/adhm.202202936.